Increased admission serum total bile acids can be associated with decreased 3-month mortality in patients with acute ischemic stroke

Table 6 Odds ratios and 95% confidence intervals of all-cause mortality at 3 months by quartiles of admission serum TBA (n=114)

TBA quartiles (µmoI/L), range (median)	Death in 3 months, n (%)	Unadjusted OR (95% CI)	Model 1 Adjusted OR (95% CI)	Model 2 Adjusted OR (95% CI)	Model 3 Adjusted OR (95% CI)
Q 1 ≤3.0 (1.8)	42 (21.3%)	1 (reference)	1 (reference)	1 (reference)	1 (reference)
Q 2 3.0-5.7 (4.4)	26 (13.3%)	0.57 (0.33-0.97)	0.44 (0.24-0.80)	0.36 (0.16-0.80)	0.36 (0.16-0.80)
Q 3 5.7-9.5 (7.3)	19 (9.9%)	0.41 (0.23-0.73)	0.34 (0.18-0.64)	0.35 (0.16-0.78)	0.30 (0.13-0.70)
Q 4 >9.5 (12.7)	27 (13.9%)	0.60 (0.35-1.01)	0.45 (0.25-0.82)	0.30 (0.14-0.66)	0.29 (0.13-0.65)
P-trend	P=0.013	0.072	0.021	0.007	0.005

Model 1, adjusted for age and sex
Model 2, adjusted for age, sex, NIHSS score on admission, stroke progression and at least one complication during hospitalization
Model 3, adjusted for age, sex, NIHSS score on admission, stroke progression and at least one complication during hospitalization, history of atrial fibrillation, admission WBC count
The admission fasting serum TBA levels were inversely associated with the 3-month mortality of AIS patients

ISSN: 1476-511X